• Protease Inhibitor Cocktail: Precision for Protein Extractio

  2026-06-16

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers researchers to safeguard protein integrity during extraction, even in phosphorylation-sensitive or co-immunoprecipitation workflows. This review unpacks experimental enhancements, troubleshooting strategies, and data-driven advantages, bridging new mechanistic insights from cancer research to bench-top protocols.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Mechan

  2026-06-16

  This research introduces a localized therapeutic strategy for bladder cancer using intravesical delivery of lipid nanoparticles loaded with chemically modified p21 mRNA. The study demonstrates robust tumor growth suppression and restoration of p21 function, offering a potential paradigm shift for targeted tumor suppressor replacement in non-muscle-invasive bladder cancer.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Studies

  2026-06-15

  Angiotensin I/II (1-5) provides researchers a defined Asp-Arg-Val-Tyr-Ile peptide for controlled modeling of blood pressure regulation and aldosterone release within the renin-angiotensin system. It is technically suited for cardiovascular and renal workflows, but should not be used in unrelated peptide or signaling studies due to its specific solubility and mechanistic profile.

• Isradipine (Dynacirc): Precision Tool for Calcium Channel Su

  2026-06-15

  Explore how Isradipine (Dynacirc) advances research in hypertension and neurodegeneration by enabling precise L-type calcium channel interrogation. This article uniquely analyzes subtype selectivity and practical assay implications, offering guidance beyond standard workflows.

• BIBP 3226 trifluoroacetate: Reliable NPY/NPFF Antagonist for

  2026-06-14

  This article provides an evidence-driven, scenario-based analysis of BIBP 3226 trifluoroacetate (SKU B7155) in cell viability, proliferation, and neuropeptide signaling research. Drawing on recent literature and validated protocols, we demonstrate how this non-peptide NPY Y1/NPFF receptor antagonist addresses reproducibility and specificity challenges in advanced biomedical assays.

• 6-FAM SE in Molecular Biology: Stability, Conjugation, and A

  2026-06-13

  Explore how 6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) redefines durable fluorescent labeling for gene sequencing and molecular probes. This article delivers a critical evaluation of conjugation chemistry, enhanced stability, and emerging assay strategies distinct from existing coverage.

• Cl-Amidine trifluoroacetate salt: Targeted PAD4 Inhibition i

  2026-06-12

  Cl-Amidine (trifluoroacetate salt) enables precise, high-specificity inhibition of PAD4, unlocking new possibilities in cancer, autoimmune, and sepsis research. This guide delivers actionable protocols, comparative advantages, and troubleshooting insights for maximizing reproducibility and translational impact.

• GSK126 EZH2 Inhibitor: Enhancing Cancer and Neuroinflammatio

  2026-06-12

  GSK126, a potent EZH2 inhibitor from APExBIO, empowers researchers to interrogate epigenetic regulation in both cancer and neuroinflammation. This article offers actionable workflow guidance and troubleshooting strategies, bridging oncology and neuropathic pain studies.

• CD28-ARS2 Axis Controls Metabolic Flexibility in CD8+ T Cell

  2026-06-11

  The referenced study reveals how the CD28-ARS2 signaling axis orchestrates alternative splicing of pyruvate kinase M, thereby enhancing metabolic flexibility in CD8+ T cells. This mechanistic insight clarifies how post-transcriptional regulation supports antitumor immunity and provides a foundation for further immunometabolic research.

• Antipyrine in BBB Permeability Assays: Protocols & Solutions

  2026-06-11

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) remains unrivaled as a benchmark for blood-brain barrier permeability and CNS drug metabolism research. This article delivers actionable workflows, protocol enhancements, and troubleshooting solutions, leveraging APExBIO's Antipyrine to streamline high-throughput pharmacokinetic and pain relief research.

• D-Luciferin Potassium Salt: Unraveling Extracellular Metabol

  2026-06-10

  Explore how D-Luciferin potassium salt empowers advanced in vivo bioluminescence imaging and luciferase assays as a uniquely water-soluble substrate. This article reveals the intersection of plant defense biochemistry and assay optimization for next-generation tumor and pathogen tracking.

• Aprotinin (BPTI): Integrative Insights into Fibrinolysis and

  2026-06-10

  Explore the advanced scientific interplay between Aprotinin (Bovine Pancreatic Trypsin Inhibitor) and red blood cell membrane rigidity, with a focus on perioperative blood loss reduction and biophysical assay optimization. This comprehensive article reveals unique translational insights for cardiovascular research.

• Antipyrine in CNS Drug Screening: Protocols, Models, and Tip

  2026-06-09

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is the gold-standard reference for blood-brain barrier (BBB) permeability and pharmacokinetic studies, facilitating reproducible CNS drug assessment. Learn how to optimize experimental workflows, leverage high-throughput surrogate models, and troubleshoot common pitfalls using APExBIO’s ultra-pure Antipyrine.

• Structure-Based Screening Reveals NSP15 Inhibitors in SARS-C

  2026-06-09

  This study identifies thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease through structure-based virtual screening and molecular dynamics simulations. The findings highlight NSP15 as a promising antiviral target, offering new avenues for drug development beyond conventional replicase inhibitors.

• RESTRICT-seq Reveals New Epigenetic Dependencies in SCC Resi

  2026-06-08

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening platform that uncovers novel epigenetic vulnerabilities in squamous cell carcinoma (SCC) resistance. This methodological advance offers researchers new avenues to dissect chromatin regulator function and identify actionable targets for oncogene-induced senescence induction.

16119 records 1/1075 page Next 12345 下5页 Last page